Skip to main content

Verification & Compliance Record

Enforcement records
Full FDA/FTC/Health Canada enforcement-records search not yet performed for Elements.
Website reachable
The listed website responded to the most recent check.

PeptideBase reports publicly documented information for educational purposes. This is not medical or legal advice, and listing does not constitute endorsement.

Are you Elements? Claim this listing to update your information and add verification.

Claim listing
503A Pharmacy

Elements

Mesa, Arizona, United States
4.116 reviewsGoogle

Elements Compounding Pharmacy is a 503A compounding facility in Mesa, Arizona that prepares customized medications including hormone replacement therapy, thyroid medications, low-dose naltrexone, and other specialty formulations for human and veterinary patients. They work with prescribers to create non-sterile compounded dosage forms such as capsules, tablets, creams, and solutions tailored to individual patient needs. Most prescriptions are processed within 24 hours, and orders can be placed by phone, fax, mail, or live chat.

Provider Details

503A Compounding Pharmacy

Prescriptions are required. Compounds are prepared to order for individual patients and cannot be sold in bulk without a physician order.

Coverage

Country
United States
State
Arizona
Telehealth
Not available
Regions Served
United States

Compliance

Compliance Type
503A Compounding

Verification & FDA Records

Data sources

  • Domain registrationRegistered Jan 2014
    Checked Jun 2026Source

Commercial relationships never influence ranking, verification status, or scoring.

0 paid placements in this directory.

Report an error

Elements

Use this form to flag incorrect data, outdated information, or a misattributed finding. Our team reviews every report.

Related providers

Track this provider

Know when Elements changes.

Get an email when their listing details, reviews, or peptide list are updated.

PeptideBase badge

Add this badge to your website

Profile last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.